HCR — Health Issues
Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxicating hemp.
Lobbyists: MATTHEW LEFFINGWELL; JOHN MICHAEL GONZALEZ; TIMOTHY A MOLINO
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
MED — Medical/Disease Research/Clinical Labs
Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services.
Lobbyists: MATTHEW LEFFINGWELL; JOHN MICHAEL GONZALEZ; TIMOTHY A MOLINO
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
BUD — Budget/Appropriations
Issues related to FDA enforcement of non-FDA approved, cannabis derived CBD products in H.R. 4121/S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; Issues related to the Ag/FDA amendment - technical correction to hemp in H.R. 4121/S. 2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; Issues related to intoxicating hemp products.
Lobbyists: MATTHEW LEFFINGWELL; TIMOTHY A MOLINO
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE